Anifrolumab real-world treatment outcomes in systemic lupus erythematosus

Trial Identifier: D3461R00082
Sponsor: AstraZeneca
Start Date: February 2025
Primary Completion Date: June 2028
Study Completion Date: June 2028
Condition: Lupus

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Poland BYDGOSZCZ, Poland
Poland BYTOM, Poland
Poland GDANSK, Poland
Poland KATOWICE, Poland
Poland KRAKOW, Poland
Poland LODZ, Poland
Poland LUBLIN, Poland
Poland POZNAN, Poland
Poland RZESZOW, Poland
Poland WARSZAWA, Poland
Poland WROCLAW, Poland